PV Bulletin

AI Sleep Data Could Provide One-Week Early Warning of Flu and COVID-19

A UKHSA study suggests that cough data from a sleep app may detect respiratory illnesses early, indicating potential increases in flu and COVID-19 cases.

Primary source: Open Government Licence v3.0

Translated From French

PV Bulletin does not take any responsibility for translation errors or omissions, though it has used the best available translation engine.

PV Impact Brief

MonitoringConfidence: medium

What changed

The study finds that cough data from the Sleep Cycle app provides early signals of respiratory illness, which could enhance existing disease surveillance systems.

Why it matters

This finding underscores the role of digital health monitoring in improving public health responses to respiratory outbreaks, which is crucial in managing potential pandemics efficiently.

Action needed

Health agencies should integrate and evaluate passive digital monitoring data, such as cough signals from sleep apps, alongside traditional surveillance systems to enhance early warning capabilities.

Relevant for
Regulatory Intelligence Lead
Processes impacted
Signal Management
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: mediumSource updated: Sep 3, 2026

Primary-source confirmation recommended before operational implementation.

Full briefing

Practical implication

Health agencies should integrate and evaluate passive digital monitoring data, such as cough signals from sleep apps, alongside traditional surveillance systems to enhance early warning capabilities.

The UK Health Security Agency (UKHSA) and Sleep Cycle conducted a study demonstrating that cough data collected through a sleep app could act as an early indicator of respiratory illness outbreaks, including flu and COVID-19. The research indicates that increases in cough frequency can be detected approximately one week prior to rising reported cases, showcasing the potential of digital health data in public health surveillance.

What changed: The study finds that cough data from the Sleep Cycle app provides early signals of respiratory illness, which could enhance existing disease surveillance systems.

Why it matters: This finding underscores the role of digital health monitoring in improving public health responses to respiratory outbreaks, which is crucial in managing potential pandemics efficiently.

Practical implication: Health agencies should integrate and evaluate passive digital monitoring data, such as cough signals from sleep apps, alongside traditional surveillance systems to enhance early warning capabilities.

View original source

  • Source: MHRA - News and communications
  • Published at source: 2026-09-03T00:00:00.000Z
  • Discovered by monitor: 2026-09-03T22:08:59.007Z

Published from the regulator source ingestion pipeline after PV impact triage.

Related updates for your role

publicEuropean Medicines Agency (EMA) · European Union · Updated Sep 4, 2026

New EU supply chain to end Visudyne shortage

Urgency: High

Monitor the supply chain developments and prepare to adjust inventory management practices as the end of the shortage approaches.

Signal ManagementSignal Management Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Signal Management Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicEuropean Medicines Agency (EMA) · European Union · Updated Sep 4, 2026Translated From French

Parenteral iron-containing medicinal products - referral

Urgency: High

Monitor for changes in labeling requirements and risk management strategies as a result of the ongoing review by PRAC.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicEuropean Medicines Agency (EMA) · European Union · Updated Sep 4, 2026Translated From French

PRAC 3 September 2026: Starts safety review of injectable iron-containing medicines Image credit: © tadamichi | stock.adobe.com Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 31 August - 3 September 2026 4 September 20

Urgency: High

Signal management teams need to prepare for potential updates in labeling, usage guidelines, and monitoring requirements for injectable iron-containing medicines.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicEuropean Medicines Agency · European Union · Updated Sep 4, 2026

Dengue Tetravalent Vaccine (Live, Attenuated) Takeda - opinion on medicine for use outside EU

Urgency: High

Regulatory compliance workflows involving the Dengue Tetravalent Vaccine outside the EU need to incorporate the EMA's positive opinion concerning its use in individuals aged 4 to 60.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward